Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 530

    1.

    Prognostic effect of insertion/deletion polymorphism of the ace gene on renal and cardiovascular clinical outcomes in Chinese patients with type 2 diabetes.

    Wang Y, Ng MC, So WY, Tong PC, Ma RC, Chow CC, Cockram CS, Chan JC.

    Diabetes Care. 2005 Feb;28(2):348-54.PMID: 15677791 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Prognostic value of angiotensin-I converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus: a prospective study.

    Hadjadj S, Belloum R, Bouhanick B, Gallois Y, Guilloteau G, Chatellier G, Alhenc-Gelas F, Marre M.

    J Am Soc Nephrol. 2001 Mar;12(3):541-9.PMID: 11181802 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Angiotensin-converting enzyme (ACE) inhibition in type 2, diabetic patients-- interaction with ACE insertion/deletion polymorphism.

    So WY, Ma RC, Ozaki R, Tong PC, Ng MC, Ho CS, Lam CW, Chow CC, Chan WB, Kong AP, Chan JC.

    Kidney Int. 2006 Apr;69(8):1438-43.PMID: 16395257 [PubMed - indexed for MEDLINE]Related articles

    4.

    Angiotensinogen T235 and ACE insertion/deletion polymorphisms associated with albuminuria in Chinese type 2 diabetic patients.

    Young RP, Chan JC, Critchley JA, Poon E, Nicholls G, Cockram CS.

    Diabetes Care. 1998 Mar;21(3):431-7.PMID: 9540028 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus.

    Yoshida H, Kuriyama S, Atsumi Y, Tomonari H, Mitarai T, Hamaguchi A, Kubo H, Kawaguchi Y, Kon V, Matsuoka K, Ichikawa I, Sakai O.

    Kidney Int. 1996 Aug;50(2):657-64.PMID: 8840299 [PubMed - indexed for MEDLINE]Related articles

    8.

    Prognostic value of the insertion/deletion polymorphism of the ACE gene in type 2 diabetic subjects: results from the Non-insulin-dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) studies.

    Hadjadj S, Fumeron F, Roussel R, Saulnier PJ, Gallois Y, Ankotche A, Travert F, Abi Khalil C, Miot A, Alhenc-Gelas F, Lievre M, Marre M; DIABHYCAR Study Group; DIAB2NEPHROGENE Study Group; SURDIAGENE Study Group.

    Diabetes Care. 2008 Sep;31(9):1847-52. Epub 2008 Jun 3.PMID: 18523145 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    ACE gene polymorphism and progression of diabetic nephropathy in Korean type 2 diabetic patients: effect of ACE gene DD on the progression of diabetic nephropathy.

    Ha SK, Park HC, Park HS, Kang BS, Lee TH, Hwang HJ, Kim SJ, Kim DH, Kang SW, Choi KH, Lee HY, Han DS.

    Am J Kidney Dis. 2003 May;41(5):943-9.PMID: 12722028 [PubMed - indexed for MEDLINE]Related articles

    10.

    Polymorphism of the ACE Gene in dialysis patients: overexpression of DD genotype in type 2 diabetic end-stage renal failure patients.

    Park HC, Choi SR, Kim BS, Lee TH, Kang BS, Choi KH, Lee HY, Han DS, Ha SK.

    Yonsei Med J. 2005 Dec 31;46(6):779-87.PMID: 16385653 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM.

    Vleming LJ, van der Pijl JW, Lemkes HH, Westendorp RG, Maassen JA, Daha MR, van Es LA, van Kooten C.

    Clin Nephrol. 1999 Mar;51(3):133-40.PMID: 10099885 [PubMed - indexed for MEDLINE]Related articles

    12.

    The relationship between the insertion/deletion polymorphism of the ACE gene and hypertension in Iranian patients with type 2 diabetes.

    Nakhjavani M, Esfahanian F, Jahanshahi A, Esteghamati A, Nikzamir AR, Rashidi A, Zahraei M.

    Nephrol Dial Transplant. 2007 Sep;22(9):2549-53. Epub 2007 May 3.PMID: 17478487 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patients.

    Wong TY, Poon P, Szeto CC, Chan JC, Li PK.

    Kidney Int. 2000 Feb;57(2):632-8.PMID: 10652041 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?

    Andersen S, Tarnow L, Cambien F, Rossing P, Juhl TR, Deinum J, Parving HH.

    Diabetes Care. 2003 May;26(5):1501-6.PMID: 12716812 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1.

    Kimura H, Gejyo F, Suzuki Y, Suzuki S, Miyazaki R, Arakawa M.

    Kidney Int. 1998 Nov;54(5):1659-69.PMID: 9844142 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Angiotensin-I-converting enzyme insertion/deletion polymorphism and high urinary albumin concentration in French Type 2 diabetes patients.

    Hadjadj S, Gallois Y, Alhenc-Gelas F, Chatellier G, Marre M, Genes N, Lievre M, Mann J, Menard J, Vasmant D; DIABHYCAR Study Group.

    Diabet Med. 2003 Aug;20(8):677-82.PMID: 12873298 [PubMed - indexed for MEDLINE]Related articles

    18.

    Association of transforming growth factor-beta (TGF-beta) T869C (Leu 10Pro) gene polymorphisms with type 2 diabetic nephropathy in Chinese.

    Wong TY, Poon P, Chow KM, Szeto CC, Cheung MK, Li PK.

    Kidney Int. 2003 May;63(5):1831-5.PMID: 12675860 [PubMed - indexed for MEDLINE]Related articles

    19.

    Angiotensin-converting enzyme insertion/deletion polymorphism and diabetic albuminuria in patients with NIDDM followed Up for 9 years.

    Huang XH, Rantalaiho V, Wirta O, Pasternack A, Hiltunen TP, Koivula T, Malminiemi K, Nikkari T, Lehtimäki T.

    Nephron. 1998 Sep;80(1):17-24.PMID: 9730698 [PubMed - indexed for MEDLINE]Related articles

    20.

    Angiotensin-converting enzyme genotype in blacks with diabetic nephropathy: effects on risk of diabetes and its complications.

    Crook ED, Genous L, Oliver B.

    J Investig Med. 2003 Nov;51(6):360-5.PMID: 14686639 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data